Hibiscus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.
Conditions: Urinary Tract Infection; Pelvic Organ Prolapse; Urinary IncontinenceInterventions: Drug: L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract; Other: PlaceboSponsor: IRCCS San RaffaeleNot yet recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2014 Category: Research Source Type: clinical trials

L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.
Conditions: Urinary Tract Infection; Pelvic Organ Prolapse; Urinary IncontinenceInterventions: Drug: L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract; Other: PlaceboSponsor: IRCCS San RaffaeleRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2014 Category: Research Source Type: clinical trials

Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency
Condition: Iron Deficiency AnemiaInterventions: Drug: Herbal medicine; Drug: IronSponsors: Casa Espirita Terra de Ismael; University of Sao PauloCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2011 Category: Research Source Type: clinical trials